159 related articles for article (PubMed ID: 36313223)
1. The Potential of Transforming Growth Factor-beta Inhibitor and Vascular Endothelial Growth Factor Inhibitor as Therapeutic Agents for Uterine Leiomyoma.
Park JY; Chae B; Kim MR
Int J Med Sci; 2022; 19(12):1779-1786. PubMed ID: 36313223
[No Abstract] [Full Text] [Related]
2. Expression, menstrual cycle-dependent activation, and bimodal mitogenic effect of transforming growth factor-beta1 in human myometrium and leiomyoma.
Arici A; Sozen I
Am J Obstet Gynecol; 2003 Jan; 188(1):76-83. PubMed ID: 12548199
[TBL] [Abstract][Full Text] [Related]
3. Human leiomyoma smooth muscle cells show increased expression of transforming growth factor-beta 3 (TGF beta 3) and altered responses to the antiproliferative effects of TGF beta.
Lee BS; Nowak RA
J Clin Endocrinol Metab; 2001 Feb; 86(2):913-20. PubMed ID: 11158066
[TBL] [Abstract][Full Text] [Related]
4. CCNs, fibulin-1C and S100A4 expression in leiomyoma and myometrium: inverse association with TGF-beta and regulation by TGF-beta in leiomyoma and myometrial smooth muscle cells.
Luo X; Ding L; Chegini N
Mol Hum Reprod; 2006 Apr; 12(4):245-56. PubMed ID: 16571622
[TBL] [Abstract][Full Text] [Related]
5. Ulipristal acetate decreases active TGF-β3 and its canonical signaling in uterine leiomyoma via two novel mechanisms.
Lewis TD; Malik M; Britten J; Parikh T; Cox J; Catherino WH
Fertil Steril; 2019 Apr; 111(4):806-815.e1. PubMed ID: 30871768
[TBL] [Abstract][Full Text] [Related]
6. Preoperative treatment of uterine leiomyomas: clinical findings and expression of transforming growth factor-beta3 and connective tissue growth factor.
De Falco M; Staibano S; D'Armiento FP; Mascolo M; Salvatore G; Busiello A; Carbone IF; Pollio F; Di Lieto A
J Soc Gynecol Investig; 2006 May; 13(4):297-303. PubMed ID: 16697947
[TBL] [Abstract][Full Text] [Related]
7. Ulipristal acetate decreases transforming growth factor β3 serum and tumor tissue concentrations in patients with uterine fibroids.
Ciebiera M; Włodarczyk M; Wrzosek M; Słabuszewska-Jóźwiak A; Nowicka G; Jakiel G
Fertil Steril; 2018 Mar; 109(3):501-507.e2. PubMed ID: 29525690
[TBL] [Abstract][Full Text] [Related]
8. Ulipristal acetate modulates the expression and functions of activin a in leiomyoma cells.
Ciarmela P; Carrarelli P; Islam MS; Janjusevic M; Zupi E; Tosti C; Castellucci M; Petraglia F
Reprod Sci; 2014 Sep; 21(9):1120-5. PubMed ID: 25001022
[TBL] [Abstract][Full Text] [Related]
9. Fibromodulin is expressed in leiomyoma and myometrium and regulated by gonadotropin-releasing hormone analogue therapy and TGF-beta through Smad and MAPK-mediated signalling.
Levens E; Luo X; Ding L; Williams RS; Chegini N
Mol Hum Reprod; 2005 Jul; 11(7):489-94. PubMed ID: 16123076
[TBL] [Abstract][Full Text] [Related]
10. The expression of Abl interactor 2 in leiomyoma and myometrium and regulation by GnRH analogue and transforming growth factor-beta.
Luo X; Levens E; Williams RS; Chegini N
Hum Reprod; 2006 Jun; 21(6):1380-6. PubMed ID: 16488906
[TBL] [Abstract][Full Text] [Related]
11. Expression of the hypoxically regulated angiogenic factor adrenomedullin correlates with uterine leiomyoma vascular density.
Hague S; Zhang L; Oehler MK; Manek S; MacKenzie IZ; Bicknell R; Rees MC
Clin Cancer Res; 2000 Jul; 6(7):2808-14. PubMed ID: 10914728
[TBL] [Abstract][Full Text] [Related]
12. Effects of GnRH analogues, 'add-back' steroid therapy, antiestrogen and antiprogestins on leiomyoma and myometrial smooth muscle cell growth and transforming growth factor-beta expression.
Chegini N; Ma C; Tang XM; Williams RS
Mol Hum Reprod; 2002 Dec; 8(12):1071-8. PubMed ID: 12468639
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth interacting factor expression in leiomyoma compared with myometrium.
Yen-Ping Ho J; Man WC; Wen Y; Polan ML; Shih-Chu Ho E; Chen B
Fertil Steril; 2010 Aug; 94(3):1078-83. PubMed ID: 19524896
[TBL] [Abstract][Full Text] [Related]
14. Adipocyte and Adipokines Promote a Uterine Leiomyoma Friendly Microenvironment.
Afrin S; Ramaiyer M; Begum UAM; Borahay MA
Nutrients; 2023 Jan; 15(3):. PubMed ID: 36771423
[TBL] [Abstract][Full Text] [Related]
15. Comparative effects of SPRM asoprisnil (J867) on proliferation, apoptosis, and the expression of growth factors in cultured uterine leiomyoma cells and normal myometrial cells.
Ohara N; Morikawa A; Chen W; Wang J; DeManno DA; Chwalisz K; Maruo T
Reprod Sci; 2007 Dec; 14(8 Suppl):20-7. PubMed ID: 18089606
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical localization of growth factors and their receptors in uterine leiomyomas and matched myometrium.
Dixon D; He H; Haseman JK
Environ Health Perspect; 2000 Oct; 108 Suppl 5():795-802. PubMed ID: 11035985
[TBL] [Abstract][Full Text] [Related]
17. Regression of uterine leiomyomata in response to the antiprogesterone RU 486.
Murphy AA; Kettel LM; Morales AJ; Roberts VJ; Yen SS
J Clin Endocrinol Metab; 1993 Feb; 76(2):513-7. PubMed ID: 8432797
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor beta and platelet-derived growth factor in human myometrium and in uterine leiomyomas at various stages of tumour growth.
Wolańska M; Bańkowski E
Eur J Obstet Gynecol Reprod Biol; 2007 Feb; 130(2):238-44. PubMed ID: 16564125
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor beta3 regulates the versican variants in the extracellular matrix-rich uterine leiomyomas.
Norian JM; Malik M; Parker CY; Joseph D; Leppert PC; Segars JH; Catherino WH
Reprod Sci; 2009 Dec; 16(12):1153-64. PubMed ID: 19700613
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor-β signaling pathway cross-talking with ERα signaling pathway on regulating the growth of uterine leiomyoma activated by phenolic environmental estrogens in vitro.
Shen Y; Wu Y; Lu Q; Zhang P; Ren M
Tumour Biol; 2016 Jan; 37(1):455-62. PubMed ID: 26224478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
